Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-006735

Options or other derivatives

  • Chief Operating Officer acquired 84,026 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Cittadine Andrew Chief Operating Officer 2025-03-04 Grant or award · Stock Options +43,445 43,445 D
Cittadine Andrew Chief Operating Officer 2025-03-04 Grant or award · Restricted Stock Units +40,581 51,655 D
Loading xslF345X05/rdgdoc.xml…